Predicting and Surviving Prolonged Critical Illness After Congenital Heart Surgery

Aaron G DeWitt1, Joseph W Rossano2, David K Bailly3

  • 1Division of Cardiac Critical Care Medicine, Departments of Pediatrics and Anesthesia & Critical Care Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA.

Insights

Prolonged critical illness after pediatric heart surgery is common, with many predictors being preventable. Identifying best practices at hospitals with lower rates can improve care and reduce mortality.

Area of Science:

  • Pediatric critical care medicine
  • Congenital heart surgery outcomes
  • Healthcare quality improvement

Background:

  • Prolonged critical illness (PCI) following congenital heart surgery (CHS) significantly impacts patients and healthcare resources.
  • Understanding predictors and variations in PCI is crucial for improving outcomes.

Purpose of the Study:

  • To define PCI, identify nonmodifiable and potentially preventable predictors of PCI and its mortality.
  • To analyze interhospital variation in PCI rates after CHS.

Main Methods:

  • Observational analysis of the Pediatric Cardiac Critical Care Consortium clinical registry.
  • Stratified analysis of neonates (≤28 days) and nonneonates (29 days to 18 years).
  • Multivariable logistic regression to identify predictors of PCI and mortality.

Main Results:

  • PCI occurred in 24% of neonates and 8% of nonneonates, with higher mortality than non-PCI patients.
  • Identified 10 neonatal and 19 nonneonatal PCI predictors; only 1 mortality predictor was nonmodifiable.
  • Approximately 40% of PCI predictors were nonmodifiable, while most mortality predictors were potentially preventable.

Conclusions:

  • While some PCI predictors are nonmodifiable, many are preventable, offering targets for intervention.
  • Complications and critical care interventions significantly influence PCI mortality.
  • Significant interhospital variation in PCI rates suggests opportunities for quality improvement by adopting practices from high-performing centers.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
211
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
185
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
317
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
261